sable bio
London
About sable bio
Sable Bio employs artificial intelligence to analyze large amounts of biomedical data to test possible drugs for toxicity. The data is then sent to drug developers to help them make safety judgments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $5.6M
- Funding stage: Seed
- Last round: Seed (Feb 2026)
- Website: sablebio.com
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Public Safety
Social Profiles
Canonical: https://fsome.com/organization/sable-bio-108732 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.